Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Catalent Inc.

Start price
Target price
Perf. (%)
€66.63
20.02.23
-
19.06.23
-36.82%
14.04.23

buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€21.86
12.04.22
-
12.04.23
-23.60%
12.04.23

buy
Nektar Therapeutics

Start price
Target price
Perf. (%)
€1.11
13.03.23
-
13.03.24
-43.01%
03.04.23

buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€182.32
26.02.23
-
26.02.24
2.35%
02.04.23

buy
Mirati Therapeutics Inc.

Start price
Target price
Perf. (%)
€39.40
10.12.22
-
10.12.23
-11.52%
02.04.23

buy
Tenet Healthcare

Start price
Target price
Perf. (%)
€37.79
21.10.22
-
21.10.23
44.22%
02.04.23

buy
Bluebird Bio Inc.

Start price
Target price
Perf. (%)
€2.97
29.03.23
-
29.03.24
-0.45%
02.04.23

Emergent Biosolutions Inc.

Start price
Target price
Perf. (%)
€7.61
18.03.23
€3.00
18.03.24
23.14%
01.04.23

buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€26.35
16.06.22
-
16.06.23
-11.95%
31.03.23

buy
Catalent Inc.

Start price
Target price
Perf. (%)
€66.20
08.03.23
-
08.04.23
-5.63%
20.03.23

Future proof or reliable business model
buy
Nektar Therapeutics

Start price
Target price
Perf. (%)
€1.14
14.03.23
-
14.04.23
-20.70%
20.03.23

buy
Nektar Therapeutics

Start price
Target price
Perf. (%)
€1.37
01.03.23
-
01.03.24
-32.23%
20.03.23

buy
Nektar Therapeutics

Start price
Target price
Perf. (%)
€1.49
05.03.23
-
05.03.24
-32.88%
17.03.23

buy
Novocure Ltd

Start price
Target price
Perf. (%)
€64.20
16.03.22
€68.00
16.03.23
-6.99%
17.03.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€36.83
03.05.22
€30.00
03.05.23
-38.60%
11.03.23

Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
buy
Invitae Corp

Start price
Target price
Perf. (%)
€2.86
12.07.22
€2.10
12.07.23
-54.35%
11.03.23

Could be worthwhile Investment >10% per year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€214.90
20.08.22
-
20.08.23
-14.30%
07.03.23

buy
Nektar Therapeutics

Start price
Target price
Perf. (%)
€1.51
24.02.23
-
24.02.24
-1.59%
04.03.23

buy
Nektar Therapeutics

Start price
Target price
Perf. (%)
€2.02
23.01.23
-
23.01.24
-28.00%
03.03.23

Risky Investment
buy
Invitae Corp

Start price
Target price
Perf. (%)
€2.14
16.10.22
-
16.10.23
-3.57%
18.02.23

Risky Investment
buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€28.11
28.10.22
-
28.10.23
3.72%
05.02.23

buy
Insulet Corp.

Start price
Target price
Perf. (%)
€228.95
16.10.22
-
16.10.23
17.08%
05.02.23

buy
Tandem Diabetes Care Inc

Start price
Target price
Perf. (%)
€55.88
16.10.22
-
16.10.23
-27.47%
05.02.23

buy
Ensign Group Inc.

Start price
Target price
Perf. (%)
€84.50
16.10.22
-
16.10.23
-0.59%
05.02.23

buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€191.98
16.10.22
-
16.10.23
11.50%
05.02.23